InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
7
T+90 hit rate
11%
T+90 mean return
-36.9%
Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by PERRY MICHAEL S, Director. Officer active across 3 companies, notably Arrowhead Pharmaceuticals, INC.. In total, 21 disclosures have been published. Breakdown: 0 buy · 7 sells. Total volume traded: €3.7m. History available since 2 June 2021. The latest transaction was filed on 5 December 2025 (Cession). Regulator: SEC (Form 4). The full history is free.
Declarations21 total
16,250 shares@ US$61.0342.6% of flowCommon StockSEC:0001250379-25-000003
16,250 shares@ US$61.030.0079% mcap42.6% of flowCommon StockSEC:0001250379-25-000003:0
16,733 shares@ US$22.9913.5% of flowCommon StockSEC:0001628280-24-052269:0
14,987 shares@ US$25.4112.8% of flowCommon StockSEC:0001628280-23-041967:0
7,867 shares0Common StockSEC:0001209191-23-003077:0
150,000 shares@ US$5.9933.9% of flowCommon StockSEC:0001209191-22-058404:0
150,000 shares@ US$7.1840.6% of flowCommon StockSEC:0001209191-22-058404:1
2,980 shares0Common StockSEC:0001209191-22-048725:0
23,754 shares0Common StockSEC:0001209191-22-033585:0
23,753 shares0Common StockSEC:0001209191-22-013222:0
6,400 shares0Common StockSEC:0001209191-22-002595
6,400 shares0Common StockSEC:0001209191-22-002595:0
2,628 shares@ US$64.300.0014% mcap7.4% of flowCommon StockSEC:0001209191-22-001318:0
2,628 shares@ US$64.300.0014% mcap14.9% of flowCommon StockSEC:0001209191-22-001318
23,800 sharesCommon StockSEC:0001209191-21-071256
23,800 sharesCommon StockSEC:0001209191-21-071256:0
23,754 shares0Common StockSEC:0001209191-21-054958:0
23,754 shares0Common StockSEC:0001209191-21-054958
23,000 shares@ US$17.330.31% mcap50.0% of flowCommon StockSEC:0001209191-21-038189:0
23,000 shares@ US$17.3312.7% of flowCommon StockSEC:0001209191-21-038189
30,000 sharesCommon StockSEC:0001209191-16-088058:0
21 of 21 declarations
About PERRY MICHAEL S
PERRY MICHAEL S serves as Chief Executive Officer of ARROWHEAD PHARMACEUTICALS, INC. and AVITA Medical, Inc. He oversees the overall operations and strategy of these companies, focusing on innovation in the healthcare sector. With extensive experience in the biopharmaceutical industry, he is responsible for guiding teams towards achieving strategic objectives and maximizing shareholder value. His leadership is essential for navigating a competitive environment.
